Price movement over the last 24 hours
Apple Inc vs Zoetis Inc — how do they compare? Apple Inc trades at $313.03 (market cap $4.56T), while Zoetis Inc trades at $75.2 (market cap $31.62B). The key difference: Apple Inc is far larger — about 144.2× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| AAPL | ZTS | |
|---|---|---|
Market Cap | $4.56T | $31.62B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $315.20 | $158.80 |
52-Week Low | $202.38 | $71.91 |
Enterprise Value | $4.58T | $38.92B |
Dividend Yield | 0.35% | 2.81% |
Signals from Pluang's Aura AI — not financial advice
AAPL trades at $310.66, down 0.64% on the day, with a bullish technical outlook supported by moving averages and strong fundamentals including a 26.91% net margin and consistent earnings beats. Revenue grew to $416.16B in 2025, and analyst consensus is a Buy with a $329.62 price target. Recent news highlights AI potential via 2.5B active devices and Gemini partnership, though store closures and union disputes pose headwinds.
The stock offers upside to consensus targets with robust cash flow and profitability, but high valuations (P/E 37.61) and competitive pressures warrant caution. Near-term focus is on Q2 2026 earnings against a $1.88 EPS expectation, with institutional activity mixed amid broader market rotation concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →